溶解物载体功能的体调节器:一个理论框架
D Boytsov1, K Schicker1, E Hellsberg2
1Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Frontiers in physiology
|May 30, 2023
概括
基于溶液载体 (SLC) 的结构药物设计可以通过考虑它们的运输机制来改进. 这项研究探讨了使用过渡状态理论和线性自由能量关系的全调节器来准SLC.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- 大规模的药物查是一种传统但费时的方法,用于识别新的化学实体.
- 随着蛋白质结构的日益普及,基于结构的虚拟查活动成为可能.
- 溶性载体 (SLC) 是有前途的药物点,因为它们与许多人类疾病有关.
研究的目的:
- 改进基于溶液载体 (SLC) 的结构药物设计方法.
- 调查使用全调节器向SLC的可行性.
- 提供一个理论框架,以了解质调节器对SLC功能的影响.
主要方法:
- 使用基于结构的对接活动 (虚拟选).
- 应用过渡状态理论.
- 使用线性自由能量关系 (LFER).
主要成果:
- 证明了将SLC运营机制纳入其中可以改进基于结构的方法.
- 展示了使用全调节器向SLC的潜力.
- 建立了分析SLCs的全调节的理论基础.
结论:
- 通过整合对其传输机制的知识,可以增强针对SLC的基于结构的药物设计.
- 基调制剂代表了针对SLC的可行策略,与基质结合配体不同.
- 过渡状态理论和LFER为了解和设计SLCs的全调节器提供了强大的框架.
相关概念视频
Membrane Transporters
11.7K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
11.7K
Allosteric Regulation
58.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.3K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.9K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.9K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Facilitated Diffusion
520
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
520
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K


